Patients Are Our Passion For 20 years, Genentech has been committed to making sure price is not a barrier to access for patients. Genentech supports several programs for eligible patients treated with Genentech therapies for approved indications in the United States who do not have insurance, cannot afford their out-of-pocket co-pay costs or need assistance with insurance reimbursement.

Through its Genentech Access Solutions program, the company provides patients with assistance and information on a broad array of coverage, reimbursement and patient assistance services and support. Since 1985, when our first product was approved, Genentech has donated approximately $1.5 billion in free medicine to uninsured patients through the Genentech® Access to Care Foundation (GATCF) and other charitable programs. Since 2005, Genentech has also donated approximately $390 million to independent non-profit organizations that provide co-pay assistance.

Consistent with Genentech's corporate mission to address the needs of people with serious or life-threatening diseases, the company also supports a number of strategic health programs managed by national organizations working to improve health care, such as our joint program with the Intercultural Cancer Center and Baylor College designed to evaluate the barriers that limit diverse populations from participating in clinical trials.